Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 34

1.

Towards the integration, annotation and association of historical microarray experiments with RNA-seq.

Chavan SS, Bauer MA, Peterson EA, Heuck CJ, Johann DJ Jr.

BMC Bioinformatics. 2013;14 Suppl 14:S4. doi: 10.1186/1471-2105-14-S14-S4. Epub 2013 Oct 9.

PMID:
24268045
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Total marrow irradiation as part of autologous stem cell transplantation for Asian patients with multiple myeloma.

Lin SC, Hsieh PY, Shueng PW, Tien HJ, Wang LY, Hsieh CH.

Biomed Res Int. 2013;2013:321762. doi: 10.1155/2013/321762. Epub 2013 Sep 8.

PMID:
24089671
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Comparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials.

Kharfan-Dabaja MA, Hamadani M, Reljic T, Nishihori T, Bensinger W, Djulbegovic B, Kumar A.

J Hematol Oncol. 2013 Jan 4;6:2. doi: 10.1186/1756-8722-6-2. Review.

PMID:
23289975
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Impact of tandem autologous stem cell transplantation and response to transplant in the outcome of multiple myeloma.

Bergantim R, Trigo F, Guimar√£es JE.

Exp Hematol Oncol. 2012 Nov 26;1(1):35. doi: 10.1186/2162-3619-1-35.

PMID:
23210890
[PubMed]
Free PMC Article
5.

Update on the role of autologous hematopoietic stem cell transplantation in multiple myeloma.

Tosi P, Imola M, Mianulli AM, Tomassetti S, Merli A, Molinari A, Mangianti S, Ratta M, Isidori A, Visani G.

Mediterr J Hematol Infect Dis. 2012;4(1):e2012069. doi: 10.4084/MJHID.2012.069. Epub 2012 Nov 5.

PMID:
23205257
[PubMed]
Free PMC Article
6.

Adoptive cellular therapy using cells enriched for NKG2D+CD3+CD8+T cells after autologous transplantation for myeloma.

Meehan KR, Talebian L, Tosteson TD, Hill JM, Szczepiorkowski Z, Sentman CL, Ernstoff MS.

Biol Blood Marrow Transplant. 2013 Jan;19(1):129-37. doi: 10.1016/j.bbmt.2012.08.018. Epub 2012 Sep 10.

PMID:
22975165
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

A phase I dose-escalation trial of high-dose melphalan with palifermin for cytoprotection followed by autologous stem cell transplantation for patients with multiple myeloma with normal renal function.

Abidi MH, Agarwal R, Tageja N, Ayash L, Deol A, Al-Kadhimi Z, Abrams J, Cronin S, Ventimiglia M, Lum L, Ratanatharathorn V, Zonder J, Uberti J.

Biol Blood Marrow Transplant. 2013 Jan;19(1):56-61. doi: 10.1016/j.bbmt.2012.08.003. Epub 2012 Aug 11.

PMID:
22892551
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Phase I trial of bortezomib during maintenance phase after high dose melphalan and autologous stem cell transplantation in patients with multiple myeloma.

Abidi MH, Gul Z, Abrams J, Ayash L, Deol A, Ventimiglia M, Lum L, Mellon-Reppen S, Al-Kadhimi Z, Ratanatharathorn V, Zonder J, Uberti J.

J Chemother. 2012 Jun;24(3):167-72. doi: 10.1179/1973947812Y.0000000004.

PMID:
22759762
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions.

Danylesko I, Beider K, Shimoni A, Nagler A.

Clin Dev Immunol. 2012;2012:753407. doi: 10.1155/2012/753407. Epub 2012 May 10. Review.

PMID:
22649466
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Bortezomib: the evidence of its clinical impact in multiple myeloma.

Lancaster S.

Core Evid. 2006;1(4):265-77. Epub 2006 Jun 30.

PMID:
22496681
[PubMed]
Free PMC Article
11.
12.

Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2.

Munshi NC, Anderson KC, Bergsagel PL, Shaughnessy J, Palumbo A, Durie B, Fonseca R, Stewart AK, Harousseau JL, Dimopoulos M, Jagannath S, Hajek R, Sezer O, Kyle R, Sonneveld P, Cavo M, Rajkumar SV, San Miguel J, Crowley J, Avet-Loiseau H; International Myeloma Workshop Consensus Panel 2.

Blood. 2011 May 5;117(18):4696-700. doi: 10.1182/blood-2010-10-300970. Epub 2011 Feb 3.

PMID:
21292777
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Efficacy and outcome of autologous transplantation in rare myelomas.

Morris C, Drake M, Apperley J, Iacobelli S, van Biezen A, Bjorkstrand B, Goldschmidt H, Harousseau JL, Morgan G, de Witte T, Niederwieser D, Gahrton G; Myeloma Subcommittee of Chronic Leukaemia Working Party of EBMT.

Haematologica. 2010 Dec;95(12):2126-33. doi: 10.3324/haematol.2010.022848. Epub 2010 Oct 22.

PMID:
20971818
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Optimizing dendritic cell-based immunotherapy in multiple myeloma: intranodal injections of idiotype-pulsed CD40 ligand-matured vaccines led to induction of type-1 and cytotoxic T-cell immune responses in patients.

Yi Q, Szmania S, Freeman J, Qian J, Rosen NA, Viswamitra S, Cottler-Fox M, Barlogie B, Tricot G, van Rhee F.

Br J Haematol. 2010 Sep;150(5):554-64. doi: 10.1111/j.1365-2141.2010.08286.x. Epub 2010 Jul 7.

PMID:
20618329
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Primary plasma cell leukemia and autologous stem cell transplantation.

Drake MB, Iacobelli S, van Biezen A, Morris C, Apperley JF, Niederwieser D, Björkstrand B, Gahrton G; European Group for Blood and Marrow Transplantation and the European Leukemia Net.

Haematologica. 2010 May;95(5):804-9. doi: 10.3324/haematol.2009.013334.

PMID:
20442444
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

How best to use new therapies in multiple myeloma.

Dingli D, Rajkumar SV.

Blood Rev. 2010 May;24(3):91-100. doi: 10.1016/j.blre.2010.03.001. Epub 2010 Apr 1. Review.

PMID:
20359801
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Novel immunotherapies.

Yi Q.

Cancer J. 2009 Nov-Dec;15(6):502-10. doi: 10.1097/PPO.0b013e3181c51f0d. Review.

PMID:
20010170
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Complete remission in multiple myeloma examined as time-dependent variable in terms of both onset and duration in Total Therapy protocols.

Hoering A, Crowley J, Shaughnessy JD Jr, Hollmig K, Alsayed Y, Szymonifka J, Waheed S, Nair B, van Rhee F, Anaissie E, Barlogie B.

Blood. 2009 Aug 13;114(7):1299-305. doi: 10.1182/blood-2009-03-211953. Epub 2009 Jun 10.

PMID:
19515721
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Impact of vitamin D deficiency on the clinical presentation and prognosis of patients with newly diagnosed multiple myeloma.

Ng AC, Kumar SK, Rajkumar SV, Drake MT.

Am J Hematol. 2009 Jul;84(7):397-400. doi: 10.1002/ajh.21412.

PMID:
19415724
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Multiple myeloma.

Rajkumar SV.

Curr Probl Cancer. 2009 Jan-Feb;33(1):7-64. doi: 10.1016/j.currproblcancer.2009.01.001. Review. No abstract available.

PMID:
19254626
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk